Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11-20190----[1] 93 💬
211C-csar----[2] 93, 94 💬
313-15MG/KG/D ursodeoxycholic----[1] 93 💬
418-22MG/KG/D ursodeoxycholic----[1] 93 💬
52MG CS0159----[1] 93 💬
63 MG [14C]-A4250 capsule----[3] 93, 297, 338 💬
73-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-YL]methyl}amino)pentanedioic acid----[1] 93 💬
83A,7A-dihydroxy-6A-ethyl-5ßcholan-24-OIC acid----[1] 93 💬
96 alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747----[1] 93 💬
106-ecdca[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
116?-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-747[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
126A-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-747[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
136A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
146A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
156A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
166A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
17A11ha02----[1] 93 💬
18A4250----[4] 93, 296, 297, 338 💬
19Abatacept[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬
[13] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[26] 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
20Acido obeticolico----[3] 93, 94, 296 💬
21Acido ursodessicolico----[1] 93 💬
22Alkaline phosphatase[1] Alkaline Phosphatase---[3] 46, 93, 97 💬
23Alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747----[1] 93 💬
24APD334----[5] 93, 96, 97, 98, 269 💬
25ASC42 10 MG----[1] 93 💬
26ASC42 15 MG----[1] 93 💬
27ASC42 5 MG----[1] 93 💬
28Atorvastatin[1] Atorvastatin[2] Atorvastatin calcium ,
Atorvastatin 💬
[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[17] 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
29Babaodan capsule----[1] 93 💬
30Baricitinib[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬
[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[19] 2, 13, 41, 46, 49, 50, 51, 53, 54, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
31BCD-085----[2] 93, 271 💬
32Bezafibrat genericon retard 400 MG----[1] 93 💬
33Bezafibrate[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[8] 20, 93, 94, 160, 296, 316, 324, 344 💬
34Bezafibrate 100 MG[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
35Bezafibrate 200 MG[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
36Bezafibrate 200 MG IN addition TO udca therapy[2] Bezafibrate,
Ursodeoxycholic acid
[2] Ursodiol ,
Bezafibrate 💬
[2] NR1C1,
NR1H4 💬
[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
37Bezafibrate 200 MG oral tablet[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
38Bezafibrate 400 MG[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
39Bezafibrate 400 MG IN addition TO udca therapy[2] Bezafibrate,
Ursodeoxycholic acid
[2] Ursodiol ,
Bezafibrate 💬
[2] NR1C1,
NR1H4 💬
[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
40Bezafibrate IR[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
41Bezafibrate SR[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
42Bezafibrate, beza, BZF, bezalip[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
43Bezafibrate, beza, BZF, bezalip mono[1] Bezafibrate[1] Bezafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
44Bezafilbrate IR----[1] 93 💬
45Bezalip----[2] 93, 94 💬
46Biological: mesenchymal stem cell----[1] 93 💬
47Budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[7] 66, 93, 94, 95, 96, 97, 98 💬
48Calcium[2] Calcium,
Calcium carbonate
[2] Calcium carbonate ,
Calcium carbonate 💬
--[12] 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
49Cilofexor[1] Cilofexor---[2] 93, 94 💬
50CNP-104----[1] 93 💬
51CNTO1275----[6] 46, 49, 84, 93, 96, 97 💬
52Colchicine[1] Colchicine[1] Colchicine 💬 [9] TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
[11] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[8] 42, 46, 50, 56, 93, 97, 210, 266 💬
53Combination antiviral therapy----[1] 93 💬
54CR845 1.0 MG----[1] 93 💬
55CS0159----[2] 93, 94 💬
56Cyclophosphamide[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬
--[44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
57Cyclosporin A[1] Cyclosporine[1] Cyclosporine 💬 [5] PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[11] 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
58Denosumab[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[10] 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬
59E6011----[4] 46, 93, 96, 97 💬
60EDP-305----[1] 93 💬
61EDP-305 dose 1----[1] 93 💬
62EDP-305 dose 2----[1] 93 💬
63Elafibranor[1] Elafibranor[1] Elafibranor 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 93, 94 💬
64Elafibranor 120 MG[1] Elafibranor[1] Elafibranor 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 93, 94 💬
65Elafibranor 80 MG[1] Elafibranor[1] Elafibranor 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 93, 94 💬
66Elafibranor 80MG[1] Elafibranor[1] Elafibranor 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
67Emtricitabine[1] Emtricitabine[1] Emtricitabine 💬 --[3] 13, 93, 325 💬
68EP547----[2] 93, 94 💬
69EP547 tablet 25MG----[2] 93, 94 💬
70EP547 tablet 75MG----[2] 93, 94 💬
71Ezetimibe[1] Ezetimibe[1] Ezetimibe 💬 [1] NPC1L1 💬 [1] Fat digestion and absorption 💬[4] 79, 93, 149, 260 💬
72Ezetrol[1] Ezetimibe[1] Ezetimibe 💬 [1] NPC1L1 💬 [1] Fat digestion and absorption 💬[2] 93, 260 💬
73EZT----[1] 93 💬
74Fecal microbiota[1] Fecal microbiota---[5] 13, 49, 93, 96, 97 💬
75Fenofibrate[1] Fenofibrate[1] Fenofibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[6] 8, 79, 93, 94, 97, 265 💬
76Fenofibrate 200MG[1] Fenofibrate[1] Fenofibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
77Fenofibrate combined with ursodeoxycholic acid[2] Fenofibrate,
Ursodeoxycholic acid
[2] Fenofibrate ,
Ursodiol 💬
[2] NR1C1,
NR1H4 💬
[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
78Fenofibrate IN combination with ursodeoxycholic acid[1] Fenofibrate[1] Fenofibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
79FFP104----[2] 93, 96 💬
80Fully human monoclonal antibody directed against CXCL10----[1] 93 💬
81Fuzhenghuayu----[1] 93 💬
82Genetic analysis----[7] 34, 85, 90, 93, 94, 96, 234 💬
83GFT505----[2] 93, 94 💬
84GKT137831----[2] 85, 93 💬
85Golexanolone[1] Golexanolone---[1] 93 💬
86GR3027----[1] 93 💬
87GS-9674----[2] 93, 94 💬
88GS-9674 100 MG----[1] 93 💬
89GS-9674 30 MG----[1] 93 💬
90GSK2330672----[1] 93 💬
91GSK2330672/linerixibat 40 MG[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
92GYPP-06 (GKT137831 free base), C10071301-D----[1] 93 💬
93Hesperidin[1] Hesperidin[1] Hesperidin 💬 --[1] 93 💬
94High protein high fiber diet----[2] 93, 95 💬
95ICG----[3] 93, 94, 235 💬
96INT-747----[1] 93 💬
97INT-747, OCA----[2] 93, 94 💬
98IPN60190----[2] 93, 94 💬
99K-808----[1] 93 💬
100Linerixibat[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
101Linerixibat (GSK2330672) 40 MG[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
102Linerixibat (GSK2330672) 45 MG[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
103Linerixibat (GSK2330672) 45MG[1] Linerixibat[1] Linerixibat 💬 [1] SLC10A2 💬 [1] Bile secretion 💬[1] 93 💬
104LJN452----[1] 93 💬
105LJN452, 0,01 MG----[1] 93 💬
106LJN452, 0,03 MG----[1] 93 💬
107LJN452, 0,1 MG----[1] 93 💬
108LUM001----[5] 93, 94, 296, 297, 338 💬
109LY3009104----[10] 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
110MBX 8025----[1] 93 💬
111MBX-8025----[3] 79, 93, 94 💬
112MBX-8025, dsic----[1] 93 💬
113MBX-8025, formulation 2----[1] 93 💬
114Methotrexate[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬
[2] DHFR,
DHFR 💬
[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[37] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
115Methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[45] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
116Methylprednisolone and azathioprine[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 93, 95 💬
117Methylprednisolone and mycophenolate mofetil[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 93, 95 💬
118Minodronic acid[1] Minodronic acid---[4] 6, 46, 93, 95 💬
119Modafinil[1] Modafinil[1] Modafinil 💬 --[4] 6, 13, 49, 93 💬
120Moexipril[1] Moexipril[2] Moexipril hydrochloride ,
Moexipril 💬
[1] ACE 💬 [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 93 💬
121Mycophenolate mofetil[2] Mycophenolate mofetil,
Mycophenolic acid
[4] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬
[2] IMPDH,
IMPDH 💬
[2] Drug metabolism - other enzymes, Purine metabolism 💬[32] 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
122Nalmefene[1] Nalmefene[3] Nalmefene hydrochloride ,
Nalmefene ,
Nalmefene hydrochloride hydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 6, 93 💬
123NCA 500MG----[1] 93 💬
124NGM282----[2] 93, 94 💬
125NI-0801----[1] 93 💬
126Norucholic acid (NCA) 500 MG[1] norUrsodeoxycholic acid---[1] 93 💬
127Obeticholic acid[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[3] 93, 265, 296 💬
128Obeticholic acid 10 MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
129Obeticholic acid 5 MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
130Obeticholic acid tablets[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
131OCA----[3] 93, 94, 296 💬
132Ocaliva[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[2] 93, 296 💬
133Ocaliva 10MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
134Ocaliva 5MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
135Olumiant[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬
[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[9] 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
136Part 1: LJN452----[1] 93 💬
137Part 2: LJN452 dose level 1----[1] 93 💬
138Part 2: LJN452 dose level 2----[1] 93 💬
139Pemafibrate[1] Pemafibrate[1] Pemafibrate 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
140Pentoxifylline[1] Pentoxifylline[1] Pentoxifylline 💬 --[11] 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
141Phenylbutyrate[1] Phenylbutyric acid[1] Sodium phenylbutyrate 💬 --[7] 2, 93, 94, 244, 251, 297, 338 💬
142Prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[54] 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
143Probiotic[1] Lactobacillus acidophilus[1] Lactomin 💬 --[9] 2, 6, 93, 96, 97, 127, 193, 266, 299 💬
144PVT201----[1] 93 💬
145Pyridoxine 10MG BP[1] Pyridoxine[2] Pyridoxine hydrochloride ,
Pyridoxine 💬
--[1] 93 💬
146Questran[1] Cholestyramine[1] Cholestyramine resin 💬 --[4] 93, 254, 297, 338 💬
147Raltegravir[1] Raltegravir[2] Raltegravir ,
Raltegravir potassium 💬
--[4] 13, 26, 93, 265 💬
148Rhudex 100 MG (127 MG rhudex choline salt) granules----[1] 93 💬
149Rhudex 25 MG (31.75 MG rhudex choline salt) granules----[1] 93 💬
150Rhudex 50 MG (63.5 MG rhudex choline salt) granules----[1] 93 💬
151Rifampicin[1] Rifampin[2] Rifampin ,
Rifampicin sodium 💬
--[8] 6, 13, 17, 46, 93, 97, 299, 338 💬
152Rifaximin[1] Rifaximin[1] Rifaximin 💬 --[8] 6, 65, 93, 96, 97, 99, 296, 299 💬
153Risedronic acid[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬
[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[3] 93, 95, 274 💬
154Rituximab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[52] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
155S-adenosyl-L-methionine----[1] 93 💬
156S-adenosyl-methionine (same) capsules----[1] 93 💬
157Saroglitazar magnesium 1 MG[1] Saroglitazar[2] Saroglitazar ,
Saroglitazar magnesium 💬
[3] NR1C1,
NR1C2,
NR1C3 💬
[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
158Saroglitazar magnesium 2 MG[1] Saroglitazar[2] Saroglitazar ,
Saroglitazar magnesium 💬
[3] NR1C1,
NR1C2,
NR1C3 💬
[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
159Saroglitazar magnesium 4 MG[1] Saroglitazar[2] Saroglitazar ,
Saroglitazar magnesium 💬
[3] NR1C1,
NR1C2,
NR1C3 💬
[22] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬[1] 93 💬
160Seladelpar[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[2] 93, 94 💬
161Seladelpar / MBX-8025 200 MG[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
162Seladelpar / MBX-8025 50 MG[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
163Seladelpar 10 MG[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
164Seladelpar 10 MG capsule[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
165Seladelpar 10 MG or less[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
166Seladelpar 5 MG[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
167Seladelpar 5 MG capsule[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
168Seladelpar 5-10 MG[1] Seladelpar[2] Seladelpar ,
Seladelpar lysine 💬
[1] NR1C3 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 93 💬
169Setanaxib[1] Setanaxib---[2] 93, 218 💬
170Sortis 10 MG----[1] 93 💬
171Standard OF care: udca----[1] 93 💬
172Sublimated mare milk----[1] 93 💬
173T cell injection targeting CD19 chimeric antigen receptor----[6] 46, 49, 51, 53, 93, 300 💬
174Tauroursodeoxycholic acid capsules[1] Tauroursodeoxycholic acid[1] Taurursodiol 💬 --[1] 93 💬
175TDF/FTC/LPV/R----[1] 93 💬
176Tenofovir disoproxil[2] Tenofovir,
Tenofovir disoproxil
[4] Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬
--[1] 93 💬
177Tetrathiomolybdate[1] Tetrathiomolybdate---[3] 85, 93, 171 💬
178Thiamine[1] Thiamine[3] Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬
--[3] 13, 93, 265 💬
179Tiamin DAK----[2] 93, 97 💬
180Tiamin SAD----[2] 93, 97 💬
181Tigecycline[1] Tigecycline[1] Tigecycline 💬 --[1] 93 💬
182TQA3526----[1] 93 💬
183Tropifexor[1] Tropifexor[1] Tropifexor 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
184Udca[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[5] 67, 93, 94, 97, 296 💬
185Umbilical cord derived mesenchymal stem cell (UC -MSC) transplantation----[2] 93, 296 💬
186Ursodeoxycholic acid[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[8] 6, 67, 84, 93, 94, 95, 96, 97 💬
187Ursodeoxycholic acid 300MG capsule[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
188Ursodeoxycholic acid 300MG tablet[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
189Ursodeoxycholic acid capsules[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
190Ursodeoxycholic acid combination OF immunosuppressive agents[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[2] 93, 95 💬
191Ursodeoxycholic acid combined with total glucosides OF paeony[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
192Ursodeoxycholic acid only[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
193UrsodeoxycholsäURE----[1] 93 💬
194Ursodiol[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[6] 8, 20, 93, 97, 234, 299 💬
195Ursofalk[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[4] 93, 94, 96, 97 💬
196Ursofalk® 500 MG FILM-coated tablets[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
197Ursofalk® 500 MG filmtabletten[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
198Ursofalk® capsules[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
199Ustekinumab[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬
[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[16] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
200Ustekinumab 180 MG[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬
[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
201Ustekinumab 45 MG[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬
[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
202Ustekinumab 90 MG[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬
[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[5] 49, 50, 93, 96, 97 💬
203Vitamin D[1] Vitamin D---[20] 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
204Volixibat[1] Volixibat[2] Volixibat potassium ,
Volixibat 💬
--[2] 93, 94 💬
205Volixibat potassium[1] Volixibat[2] Volixibat potassium ,
Volixibat 💬
--[2] 93, 94 💬
206Zoledronic acid[1] Zoledronic acid[5] Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬
[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[13] 6, 13, 46, 75, 77, 93, 95, 96, 97, 270, 274, 299, 333 💬